Article
Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Anticancer research - 1 Jan 2000
Sjöqvist Urban, Tribukait Bernhard, Ost Ake, Einarsson Curt, Oxelmark Lena, Löfberg Robert
Abstract excerpt
BACKGROUND & AIMS: There is an increased risk of colorectal carcinoma (CRC) in patients with longstanding, extensive colonic inflammatory bowel disease (IBD). Primary sclerosing cholangitis, family history of CRC, mucosal dysplasia and DNA-aneuploidy are other risk factors. Recently, results from animal studies have shown that the bile acid ursodeoxycholic acid (UDCA) has a favourable impact on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
